Introduction to Athersys Clinical Spotlight
Welcome to our comprehensive guide on Athersys Clinical Spotlight. Hi I'm Solomon wots and Welcome to the arm
Athersys Clinical Spotlight Comprehensive Overview
Dr. Sarah Busch gives an overview of the exciting preclinical research being conducted by Athersys Robert Mays, Ph.D., VP of Regenerative Medicine and Head of Neuroscience Cleveland, OH (NASDAQ: ATHX)
Gil Van Bokkelen, Ph.D., Chairman & CEO (NASDAQ: ATHX) Headquarters: Ohio, U.S.
Summary & Highlights for Athersys Clinical Spotlight
- Gil Van Bokkelen, Ph.D., Chairman and CEO Cleveland, OH (NASDAQ: ATHX)
- Presented by: Gil Van Bokkelen, Ph.D., Chairman & CEO
- Treating COVID-19 is of great interest right now. MultiStem, a therapy developed by
- ATHERSYS
- Gil Van Bokkelen, Ph.D., Chairman & CEO Cleveland, OH (NASDAQ: ATHX)
In summary, understanding Athersys Clinical Spotlight gives us a better perspective.